These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16225256)

  • 21. Detection of lupus anticoagulant and successful anticoagulation in familial Sneddon syndrome.
    Tily H; Banki K; Hoffman GS; Perl A
    Ann Rheum Dis; 2010 Apr; 69(4):775-6. PubMed ID: 20237126
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome.
    Meyer O; Worm M; Kiesewetter H; Salama A
    Thromb Haemost; 2007 Dec; 98(6):1368-70. PubMed ID: 18064338
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus.
    Tincani A; Meroni PL; Brucato A; Zanussi C; Allegri F; Mantelli P; Cattaneo R; Balestrieri G
    Clin Exp Rheumatol; 1985; 3(4):321-6. PubMed ID: 4085163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients.
    Francès C; Papo T; Wechsler B; Laporte JL; Biousse V; Piette JC
    Medicine (Baltimore); 1999 Jul; 78(4):209-19. PubMed ID: 10424203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome.
    Uthman IW; Khamashta MA
    J Rheumatol; 2006 Dec; 33(12):2379-82. PubMed ID: 17143977
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and epidemiological aspects in the antiphospholipid syndrome.
    Cervera R; Asherson RA
    Immunobiology; 2003; 207(1):5-11. PubMed ID: 12638896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
    Przepiera-Będzak H; Brzosko M
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
    Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
    Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sneddon syndrome with detection of anti-phospholipid antibodies].
    Wand A; Jünger H
    Hautarzt; 1992 Jun; 43(6):380-2. PubMed ID: 1628973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid antibody syndrome. A literature review.
    Lao M; Setty S; Foss C
    Minn Med; 2001 Apr; 84(4):42-6. PubMed ID: 11367816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
    Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
    Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spontaneous abortions in Sneddon's syndrome].
    Dikova Ch; Kolarov G; Baleva M; Nikolov K
    Akush Ginekol (Sofiia); 2000; 39(2):24-5. PubMed ID: 10948615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
    Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features.
    Alessandri C; Agmon-Levin N; Conti F; Perricone C; Ortona E; Pendolino M; Capozzi A; Delunardo F; Mancini R; Truglia S; Spinelli FR; Ceccarelli F; Sorice M; Shoenfeld Y; Valesini G
    Immunol Res; 2017 Apr; 65(2):524-531. PubMed ID: 28215033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
    De Craemer AS; Musial J; Devreese KM
    J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.